The effect of feeding on CO2 production and energy expenditure in ponies measured by indirect calorimetry and the 13C-bicarbonate technique

Energy expenditure (EE) can be estimated based on respiratory gas exchange measurements, traditionally done in respiration chambers by indirect calorimetry (IC). However, the ¹³C-bicarbonate technique (¹³C-BT) might be an alternative minimal invasive method for estimation of CO₂ production and EE in the field. In this study, four Shetland ponies were used to explore the effect of feeding on CO₂ production and EE measured simultaneously by IC and ¹³C-BT. The ponies were individually housed in respiration chambers and received either a single oral or intravenous (IV) bolus dose of ¹³C-labelled sodium bicarbonate (NaH¹³CO₃). The ponies were fed haylage 3 h before (T₋₃), simultaneously with (T₀) or 3 h after (T₊₃) administration of ¹³C-bicarbonate. The CO₂ produced and O₂ consumed by the ponies were measured for 6 h with both administration routes of ¹³C-bicarbonate at the three different feeding times. Feeding time affected the CO₂ production (P<0.001) and O₂ consumption (P<0.001), but not the respiratory quotient (RQ) measured by IC. The recovery factor (RF) of ¹³C in breath CO₂ was affected by feeding time (P<0.01) and three different RF were used in the calculation of CO₂ production measured by ¹³C-BT. An average RQ was used for the calculations of EE. There was no difference between IC and ¹³C-BT for estimation of CO₂ production. An effect of feeding time (P<0.001) on the estimated EE was found, with higher EE when feed was offered (T₀ and T₊₃) compared with when no feed was available (T₋₃) during measurements. In conclusion, this study showed that feeding time affects the RF and measurements of CO₂ production and EE. This should be considered when the ¹³C-BT is used in the field. IV administration of ¹³C-bicarbonate is recommended in future studies with horses to avoid complex ¹³C enrichment-time curves with maxima and shoulders as observed in several experiments with oral administration of ¹³C-bicarbonate.